Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Details)

v3.24.1
Significant Accounting Policies (Details)
$ in Millions
12 Months Ended
Jan. 01, 2024
shares
Jan. 01, 2023
shares
Dec. 31, 2023
USD ($)
segment
shares
Dec. 31, 2022
USD ($)
shares
Mar. 17, 2015
Significant Accounting Policies          
Number of operating segments     1    
Number of reportable segments     1    
Fortress Biotech, Inc          
Significant Accounting Policies          
Percentage of shares issued for offering and annual equity fee 2.50% 2.50%     2.50%
Number of shares issued and sold | shares 1,492,915 368,907 398,660 56,671  
Research and development          
Significant Accounting Policies          
Value of common stock shares issued | $     $ 3.4 $ 1.9